Get started

Growth

$KLSE-INFOTEC FYE2023 Number of workforce (Employees)INDEX:KLSE -INFOTEC Number of workforce (Employees): 26 permanent + 5 contract = 31 employees in total (dated LPD 23 May 2022, reported in IPO Prospectus dated 20 June 2022, page 132) 60 employees in total (dated 31 May 2023, reported in NST News). The number of employees have been doubled in a year, indicating rapid and aggressive APAC regional expansions have taken place. Important point emphasized in the NST news: The team is still growing in line with its expansion drive. That would translate into that more employees are expected onboard driven by continual business growth and in turn additional employees will push growth further on.
ILong
by Vidya2
Can ROKU run before earnings? LONGROKU on a daily chart is sitting on support in consolidation since the trend down after the last earnings report. In three weeks there will be another report. The prior report showed negative earnings but it did beat the estimates while revenues were a mild surprise. I expect ROKU has done some belt trimming to try to get expenses decreased while growing revenues. My long trade here is from thin support but targets the Fibonacci level of a retracement back to recent high pivots. The target is 80 representing 30% upside. A stop loss will be initially set at 61 but then raised 3.5% every time price rises 3% to gradually tighten it. I will take a good part of the hopeful profits off the table a few days before the upcoming report.
NASDAQ:ROKULong
by AwesomeAvani
2
MCD is topped out the long fast food trend may be SHORTMCD lives on people liking what they eat and eating a lot of it. The Happy Meal is famous. into the business model comes the new wave biologics for obesity and diabetes. the shots that cut down the weight and the food addiction. Insurance companies are jumping on the bandwagon. 1/3 of the people eat half the food. Increasingly, those people are seeking treatment. The fastfood executives know this. Same for the sugar beverages. Anyway, enough said. MC on the monthly chart is stuck at a double top even more obvious on a weekly or daily chart. At present it is stuck in a symmetrical triangle compressing price. The mathematical predictive algorithm forecasts price will move down the remainder of this year. I respect the mathematics and understand the medical trend. LLY makes money supplying insulin and now it makes money actually reversing diabetes and obesity. One way or another it makes money and MCD is supplying the patient flow. In the meanwhile if those patients are detoxified and lower their caloric intake, MCD is the one that suffers a regression of the growth story. I am short MCD and add to my position whenever there is a little upward price movement. Yeah, comarketing donuts with Krispy is an act of desperation.
NYSE:MCDShort
by AwesomeAvani
SWIMMING with the WHALES, a dangerous move, NEXT TARGET $Whales waited, Retail traders PLUNGED, then WHALES SOLD. Know your game. Dont get maneuvered into the FEARLESS CROUD. Whales red downtrend regression. Showing a deep analysis behind the scenes of BITCOIN. Shows who’s in, who’s out within the time as the white trend moves. Follow each zigzag and know how it all started. Next target is kept secret: this helps keep smart money intruders from changing directions.
COINBASE:BTCUSDLong
by The_ForexX_Mindset
49
$HTOO: Potential Bullish Reversal - Solid News & Webcast Ticker NASDAQ:HTOO - Fusion Fuel Green PLC We could be looking at a nice test and cross of the Ichimoku Cloud, here represented on a 1 Month chart. This price movement is also accompanied with news regarding the selection and acceptance of a 650M$ project funded by the EU, which Fusion Fuel proposed in regards to the hydrogen transition, please read in more detail below in the press release of Feb.16 2024. There is also a Webcast for investors on March 6th, which could lead to some updates on positive revenue forecast and more details over the 650M$ project and next steps. This company is currently valued at around 32M$, which could be undervalued if this project goes forward, IMO. I'll be sitting long in the short to mid-term and might sell for profits at some critical levels. Happy trading.
NASDAQ:HTOOLong
by O_Bl_Trader
INFOLINE TEC GROUP@KLSE : OCROICₘₒ𝒹 based ValuationINFOLINE TEC GROUP@KLSE OCROICₘₒ𝒹 based Valuation OCROICₘₒ𝒹 = 100×(6,325+(7,419+29,115+2,105)-(1,836+6,312+3,312+5,216))÷(58,317+4,879+407+107+(7,419+29,115+2,105)-(1,836+6,312+3,312+5,216)) = 33.0185706115 OCPS = (6,325+(7,419+29,115+2,105)-(1,836+6,312+3,312+5,216))÷363,229 = RM 0.0778792442 OCROICₘₒ𝒹 based Intrinsic Value (min) with 3.5% inflation rate = RM 0.0778792442×(1-(1÷1.035)^33.0185706115)÷(1-(1÷1.035)) = RM 1.5634207107 OCROICₘₒ𝒹 based Intrinsic Value (max) = RM 33.0185706115×0.0778792442 = RM 2.5714613246
ILong
by Vidya2
EL jumps on analyst upgrade LONGEL like ULTA was beaten down in covid times. It jumped in 2021 and fell in 2022 and 2023. 2024 might be the year they thrive again. On the weekly chart, EL is back to the support of its levels of 2018. With an analyst upgrade coming from Bank of America it is now getting a bit of attention. Trend strength and relative strength were down. I see this as a good entry for a new long position in EL while also looking at ULTA. Targets are the fib zone and a correction / consolidation area on the downtrend so 200 and 250. Now is the time to invest in female beauty.....
NYSE:EL
by AwesomeAvani
CMG to split price SHORTCMG has announced a split. Makes sense to make shares more affordable but fractionals are widely available. CMG may be fundamentally challenged by the underpinnings of the fast food markets. that is overeating and rising prices. In the meanwhile the anti-obesity and anti- diabetes trends are pushing hard led by the bological injectable meds from LLY, NVO and others. One third of the people eat one half of the food and now an effective treatment for that addiction is becoming increasingly available. The writing is on the wall and food biz executives can read that writing. Enough said. I am going short on CMG. It's best days of growth may behind it. The company announced plans for 4000 more stores nationwide. Really? Time will tell. I vote with my wallet. My position will not be small. The predictive algo has its forecast. My education included both medicine and engineering. I understand the power of biology and mathematics. I deeply respect both.
NYSE:CMGShort
by AwesomeAvani
AAPL on a wide view continues SHORTAAPL on the weekly continues to fall from a double top put in at 195 in July 23 and this past January. China issues are looming with competition domestically within China, factory issues and the recession. The hart shows an established trend down seeking support at the Fibonacci level in blue. The predictive algo looking back an the regression line pattern forecasts a continued fall through the fib zone into the 125 area. Indicators are all consistent with the same. I have a deep respect for advanced mathematics and will comply with the forecast. AAPL is a short and the little retrace up is an opportunity to add to my positions.
NASDAQ:AAPLShort
by AwesomeAvani
2
LITM a lithium penny stock gets momentum LONGLITM is a lithium mining company with operations is Western USA and Canada now getting a lift as lithium prices are rising. It popped 16% today and hit a screener on volume yesterday. This is a junior miner compared with LAC and SGML. As such it is more reactive to price. All indicators confirm the move including the extent of the trend, relative volume spiking and the RS lines. This is a low float low volume stock. Accumulation of a low float could precipitate more price action upward quite easily. As a volatile penny stock LITM is risky. Right now, I see a long trade in a small position ( < 0.001 of account balance) for the potential gain despite the obvious risk SL at 10% Targets at 10% 20% (red line pivots to the left-1.2o December to Feb) then 70% ( pivot low March 23) and finally 250% for the runners ( January and July 23 high pivots). Time will tell. I expect great profit in this swing trade with stratified partial profits and less time effort in the trend using alerts and notifications. A trailing loss will be employed at 10% once the trade is over 20% profit.
NASDAQ:LITMLong
by AwesomeAvani
LCTX gets upgrade and is technically setup LONGLCTX on the weekly chart here has been falling since late 2021 and found support at the bottom of the high volume area of the volume profile and ranged between it and the POC line for the past 18 months. The is a high end clinically active biotechnology firm using stem cells to produce therapeutic cell lines . ( One experiment using the mammary glands of cows imbedded with cells that make insulin to make a weak milk solution containing insulin and then concentrate it for cheap insulin is quite remarkable- ) How about some special milk for to have with your sugar buzz) see more in the here link en.wikipedia.org Anyway, price rose into triple confluence- the anchored mean VWAP, the POC line, the upper boundary of the high volume area. A new analysis targets 7. Smart money is paying attention. My smart money is paying a lot of attention. I understand the science and the market that LCTX could reach in due time. I am not an insider but close. Enough said. My target is the tweezer tops of 2022 at 2.5 and so 65-70% upside in the near to intermediate term and after that maybe the analysis will revise the target up or down I am guessing the former.
AMEX:LCTXLong
by AwesomeAvani